Nav: Home

Kaiser Permanente study shows women with more social connections have higher breast cancer survival

December 12, 2016

In a large Kaiser Permanente study of women with invasive breast cancer, socially integrated women -- those with the most social ties, such as spouses, community ties, friendships and family members -- were shown to have significantly lower breast cancer death rates and disease recurrence than socially isolated women. This study was published today in the American Cancer Society journal Cancer.

"It is well established that women who have more social ties generally, including those with breast cancer, have a lower risk of death overall," said Candyce H. Kroenke, ScD, MPH, a research scientist with the Kaiser Permanente Northern California Division of Research and lead author of the study. "Our findings demonstrate the beneficial influence of women's social ties on breast cancer-specific outcomes, including recurrence and breast cancer death."

This is believed to be the largest study to date of social networks -- the web of personal relationships that surround an individual -- and breast cancer survival. Funded by the National Cancer Institute, the study included 9,267 women diagnosed with stages 1 to 4 invasive breast cancer enrolled in the After Breast Cancer Pooling Project, a pooled cohort of four studies of women with breast cancer, including one conducted at Kaiser Permanente Northern California. Data was collected and analyzed from breast cancer survivorship studies conducted in California, Utah, Oregon, Arizona, Texas and Shanghai, China. Researchers examined how a range of lifestyle factors -- including exercise, diet, weight management and social factors -- affect breast cancer survivorship.

Within two years of a breast cancer diagnosis, women answered surveys about their personal relationships and social networks, including spouses or partners; religious, community and friendship ties; and the number of first-degree, living relatives. They were followed for up to 20 years.

The women were characterized as socially isolated (few ties), moderately integrated, or socially integrated (many ties). The large sample size allowed researchers to control for numerous factors that might confound results.

Compared to socially integrated women, the study found that socially isolated women were:
  • 43 percent more likely to have a recurrence of breast cancer
  • 64 percent more likely to die from breast cancer
  • 69 percent more likely to die from any cause
Despite these findings, Kroenke noted that the results also point to complexity, in that not all types of social ties were beneficial to all women.

For example, researchers found that older white women without a spouse or partner were 37 percent more likely to die from breast cancer than older white women with one, a relationship that wasn't apparent in other demographic groups. By contrast, non-white women with few friendships were 40 percent more likely to die of breast cancer than those with many friendship ties, and non-white women with fewer relatives were 33 percent more likely to die of breast cancer than those with many relative ties, relationships that were not apparent in white women.

"The types of social ties that mattered for women with breast cancer differed by sociodemographic factors including race/ethnicity, age and country of origin," Kroenke noted. "Ultimately, this research may be able to help doctors tailor clinical interventions regarding social support for breast cancer patients based on the particular needs of women in different sociodemographic groups."

The study builds on previous research by Kroenke and colleagues who found that positive social interactions are related to higher quality of life in breast cancer patients; high-quality personal relationships are related to better survival; and larger networks are related to healthy lifestyle factors.
-end-
In addition to Kroenke, co-authors were Marilyn L. Kwan, PhD, and Bette J. Caan, DrPH, Kaiser Permanente Division of Research; Yvonne Michael, PhD, Drexel University School of Public Health; Elizabeth Poole, ScD, and Wendy Y. Chen, MD, Brigham and Women's Hospital; Sarah Nechuta, PhD, and Xiao-Ou Shu, MD, Vanderbilt University School of Medicine; Eric Leas, PhD, and John Pierce, PhD, San Diego Moores Cancer Center, University of California, San Diego; and Ying Zheng, PhD, Dana Farber Cancer Institute.

About the Kaiser Permanente Division of Research

The Kaiser Permanente Division of Research conducts, publishes and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. It seeks to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR's 550-plus staff is working on more than 350 epidemiological and health services research projects. For more information, visit http://www.dor.kaiser.org or follow us @KPDOR.

About Kaiser Permanente

Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve more than 10.6 million members in eight states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to: kp.org/share.

Kaiser Permanente

Related Breast Cancer Articles:

Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
Blood test offers improved breast cancer detection tool to reduce use of breast biopsy
A Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results and potentially reduce biopsies up to 67 percent.
Surgery to remove unaffected breast in early breast cancer increases
The proportion of women in the United States undergoing surgery for early-stage breast cancer who have preventive mastectomy to remove the unaffected breast increased significantly in recent years, particularly among younger women, and varied substantially across states.
Breast cancer patients with dense breast tissue more likely to develop contralateral disease
Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the contralateral breast, according to new research from The University of Texas MD Anderson Cancer.
Some early breast cancer patients benefit more from breast conservation than from mastectomy
Breast conserving therapy (BCT) is better than mastectomy for patients with some types of early breast cancer, according to results from the largest study to date, presented at ECC2017.
One-third of breast cancer patients not getting appropriate breast imaging follow-up exam
An annual mammogram is recommended after treatment for breast cancer, but nearly one-third of women diagnosed with breast cancer aren't receiving this follow-up exam, according to new findings presented at the 2016 Annual Clinical Congress of the American College of Surgeons.
Low breast density worsens prognosis in breast cancer
Even though dense breast tissue is a risk factor for breast cancer, very low mammographic breast density is associated with a worse prognosis in breast cancer patients.
Is breast conserving therapy or mastectomy better for early breast cancer?
Young women with early breast cancer face a difficult choice about whether to opt for a mastectomy or breast conserving therapy (BCT).
Breast density and outcomes of supplemental breast cancer screening
In a study appearing in the April 26 issue of JAMA, Elizabeth A.
Full dose radiotherapy to whole breast may not be needed in early breast cancer
Five years after breast-conserving surgery, radiotherapy focused around the tumor bed is as good at preventing recurrence as irradiating the whole breast, with fewer side effects, researchers from the UK have found in the large IMPORT LOW trial.

Related Breast Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...